About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Houston | 22,469 Studies Near You

Clinical TrialsHouston

Clinical Trials in Houston

Discover 22,469 clinical trials near Houston, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 201-220 of 22,469 trials

RecruitingPhase1 Basket Trial Of CAR.70-Engineered IL15-Transduced With TGFBR2 Knock Out Cord Blood-Derived NK Cells For Relapsed/Refractory Lymphoid MalignanciesThis is a phase 1 basket trial of TGFBR2 KO CAR27/IL-15 NK cells after lymphodepleting chemotherapy for patients with R/R B-NHL, HL, T-NHL or B-ALL.NCT07444632·Houston, Texas Completed(CB-01-02/01) Randomized Placebo Controlled Trial of Budesonide-multi-matrix System (MMX™) 6 mg and 9 mg in Patients With Ulcerative ColitisThe purpose of this study is to compare Budesonide MMX™ 6 mg and Budesonide MMX™ 9 mg tablets to placebo and to Asacol 6x 400 mg tablets over an 8-week treatment period to…NCT00679432·Huntsville, Alabama and 104 others

Find Trials by Condition in Houston

Breast Cancerin Houston Lung Cancerin Houston Prostate Cancerin Houston Colorectal Cancerin Houston Melanomain Houston Leukemiain Houston Lymphomain Houston Pancreatic Cancerin Houston Ovarian Cancerin Houston Brain Cancerin Houston Diabetes

Data from ClinicalTrials.govTerms

Active not recruitingA Study of Rapcabtagene Autoleucel in Active, Refractory Systemic Lupus Erythematosus (SLE) or Lupus Nephritis (LN) Patients (AUTOGRAPH - SLE/LN)The purpose of this study is to evaluate the efficacy and safety of rapcabtagene autoleucel (administered once following lymphodepletion) in patients with active, refractory…NCT06581198·Birmingham, Alabama and 106 others

CompletedHyperlipidemia and Statin Therapy in Amyotrophic Lateral SclerosisThe role of hyperlipidemia and lipid lowering therapy (LLT) in Amyotrophic Lateral Sclerosis (ALS) pathophysiology and its impact on disease progression and survival is unclear.NCT01592084·Houston, Texas

RecruitingI-DECIDE After Bronchiolitis HospitalizationAlthough automatic follow-up is a nearly universal practice, research has shown that these visits are often unnecessary after hospitalizations caused by bronchiolitis.NCT07243652·Birmingham, Alabama and 61 others

CompletedTwo Doses of Multimeric-001 (M-001) Followed by Influenza VaccineThis is a Phase II randomized, double-blind, placebo-controlled trial in 120 males and non-pregnant females, 18 to 49 years old, inclusive, who are in good health and meet all…NCT03058692·Iowa City, Iowa and 2 others

CompletedA Study of the Gore VIABAHN BX for Treatment of Occlusive Disease in the Iliac Arteries.Evaluation of the Gore(R) VIABAHN BX for the treatment of arterial occlusive disease in the common and/or external iliac arteries.NCT02080871·Phoenix, Arizona and 26 others

CompletedDecitabine and Gemtuzumab Ozogamicin in Acute Myelogenous Leukemia and High-risk Myelodysplastic SyndromeThe goal of this clinical research study is to learn if giving 5-aza-2 deoxycytidine (decitabine) in combination with Mylotarg (gemtuzumab ozogamicin) can help to control AML or…NCT00968071·Houston, Texas

CompletedStudy of Pazopanib and Vorinostat in Patients With Advanced MalignanciesThe goal of this clinical research study is to find the highest tolerable dose of the combination of pazopanib and vorinostat that can be given to patients with advanced cancer.NCT01339871·Houston, Texas

CompletedWearable Lower Extremity Exoskeleton to Promote Walking in Persons With Multiple SclerosisThe purpose of this study is to investigate whether a wearable robotic exoskeleton can help people with multiple sclerosis (MS) to walk again.NCT02519244·Houston, Texas

UnknownA Study to Determine the Safety of BTP-114 for Treatment in Patients With Advanced Solid Tumors With BRCA MutationsThis is a phase 1, Open-label, multicenter Dose Escalation study of BTP-114, a novel platinum product, in patients with advanced solid tumors and BRCA or other DNA repair mutation.NCT02950064·Sarasota, Florida and 7 others

TerminatedTo Assess Efficacy and Safety of Batoclimab in Adult Participants With Active CIDPThis is a multi-center, randomized, quadruple-blind, placebo-controlled study to evaluate the efficacy and safety of batoclimab in adult participants with active CIDP.NCT05581199·Scottsdale, Arizona and 97 others

CompletedA Study of Decitabine Given Subcutaneously to Adults With Low or Intermediate-1 Risk Myelodysplastic Syndromes (MDS)The purpose of this study is to determine the effectiveness and safety of two different dose schedules of DACOGEN® (decitabine) for Injection in patients with Myelodysplastic…NCT00619099·Canton, Ohio and 3 others

RecruitingLarotrectinib for the Treatment of NTRK Amplification Positive, Locally Advanced or Metastatic Solid TumorsThis phase II trial studies the effect of larotrectinib in treating patients with NTRK gene amplification positive solid tumors that have spread to nearby tissues or lymph nodes…NCT04879121·Houston, Texas

CompletedStudy of TVB-2640 in Subjects With Nonalcoholic Steatohepatitis (NASH)This is a Phase 2, multi-center, double-blind, randomized, placebo-controlled study to evaluate the safety and efficacy on TVB-2640 in subjects with non-alcoholic steatohepatitis…NCT04906421·Huntsville, Alabama and 116 others

CompletedVaccine Therapy in Treating Patients With Chronic Myelogenous LeukemiaRATIONALE: Vaccines may make the body build an immune response to kill cancer cells.NCT00004052·New York, New York and 1 other

TerminatedSafety & Efficacy of BPL's High Purity FACTOR X in Treatment of Factor X Deficient Subjects Undergoing SurgeryTo primary efficacy variable is to assess the presence or absence of excessive blood loss during and after surgery. The secondary efficacy endpoints are as follows: 1.NCT01086852·Houston, Texas and 6 others

CompletedPhase IIA Open Label Study to Evaluate Efficacy and Safety of BL-8040 Followed by (hATG), Cyclosporine and Methyprednisolone in Adult Subjects With Aplastic Anemia or Hypoplastic Myelodysplastic SyndromeAn open label single arm study to assess efficacy and safety of BL-8040 on top of standard immunotherapy regimen of hATG, cyclosporine and steroids in patients with Hypoplastic…NCT02462252·Houston, Texas

TerminatedA Study of TAS-120 in Patients With Metastatic Breast CancerThe purpose of the trial is to evaluate a patient's response to a Fibroblast Growth Factor Receptor (FGFR) inhibitor, futibatinib (TAS-120), used either alone or in combination…NCT04024436·Phoenix, Arizona and 36 others

CompletedA Study to Evaluate MORF-057 in Adults With Moderately to Severely Active UCThis is a Phase 2b randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of three active dose regimens of MORF-057 in adult patients with…NCT05611671·Sun City, Arizona and 101 others

PreviousPage 11 of 1124Next

in Houston

Heart Diseasein Houston